{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-007460","form_type":"8-K","ticker":null,"cik":"0001401395","company_name":"Neptune Wellness Solutions Inc.","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.062607+00:00","generated_at":"2026-06-04T22:57:48.119860+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Neptune Wellness appoints interim CEO and COO after departing prior CEO","bullets":["Michael De Geus named interim President and CEO effective March 8, 2024; compensation $20,000/month.","Cedrick Billequey appointed interim COO; receives CAD$10,000/month raise on current salary.","Prior CEO Michael Cammarata departed after furlough; De Geus had served on Restructuring Committee.","De Geus is a former US Secret Service executive; Billequey led profitable Biodroga subsidiary."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-007460","json":"https://secwatch.observer/filing/0001437749-24-007460.json","markdown":"https://secwatch.observer/filing/0001437749-24-007460.md","text":"https://secwatch.observer/filing/0001437749-24-007460.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401395/000143774924007460/0001437749-24-007460-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401395/000143774924007460/nept20240312_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:57:48.119860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d55a24ef1","claim":"Michael De Geus was appointed as Interim President and Chief Executive Officer at Neptune Wellness Solutions Inc..","evidence_excerpt":"appointed Board member Michael De Geus as its interim President and Chief Executive Officer, and Cedrick Billequey, General Manager of the Company’s subsidiary, Biodroga Nutraceuticals, Inc. (“Biodroga”), as its Interim Chief Operating Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401395/000143774924007460/0001437749-24-007460-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"66cf70faae","claim":"Cedrick Billequey was appointed as Interim Chief Operating Officer at Neptune Wellness Solutions Inc..","evidence_excerpt":"appointed Board member Michael De Geus as its interim President and Chief Executive Officer, and Cedrick Billequey, General Manager of the Company’s subsidiary, Biodroga Nutraceuticals, Inc. (“Biodroga”), as its Interim Chief Operating Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401395/000143774924007460/0001437749-24-007460-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}